Resource and cost considerations in treating hypoplastic left heart syndrome
Miguel Urencio,1 Chris Greenleaf,1 Jorge D Salazar,2 Ali Dodge-Khatami2 1Division of Cardiothoracic Surgery, 2Children’s Heart Center, University of Mississippi Medical Center, Jackson, MS, USA Abstract: Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, wh...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | Pediatric Health, Medicine and Therapeutics |
Subjects: | |
Online Access: | https://www.dovepress.com/resource-and-cost-considerations-in-treating-hypoplastic-left-heart-sy-peer-reviewed-article-PHMT |
_version_ | 1819043223931191296 |
---|---|
author | Urencio M Greenleaf C Salazar JD Dodge-Khatami A |
author_facet | Urencio M Greenleaf C Salazar JD Dodge-Khatami A |
author_sort | Urencio M |
collection | DOAJ |
description | Miguel Urencio,1 Chris Greenleaf,1 Jorge D Salazar,2 Ali Dodge-Khatami2 1Division of Cardiothoracic Surgery, 2Children’s Heart Center, University of Mississippi Medical Center, Jackson, MS, USA Abstract: Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, when surgical treatment was first undertaken with the Norwood I operation as the first of 3-staged operations. Since then, operative survival rate of stage I has risen from 53% to over 90% in the current era, not only thanks to technical advances in surgery but also through prenatal diagnosis and imaging, enhanced cardiopulmonary bypass technology, better perioperative intensive care, and closer interstage monitoring. The improvements in patient outcomes achieved through rigorous multidisciplinary teamwork have come at a tremendous cost in manpower and resources, making HLHS still a challenge to all congenital heart programs, established or emerging. We review the various surgical steps to treat HLHS and their current expected outcomes, and put into perspective cost considerations compared to other more “simple” congenital heart defects. Keywords: hypoplastic left heart syndrome, Norwood, congenital heart disease |
first_indexed | 2024-12-21T09:53:23Z |
format | Article |
id | doaj.art-34b592473f41406cba0d194d2f032c62 |
institution | Directory Open Access Journal |
issn | 1179-9927 |
language | English |
last_indexed | 2024-12-21T09:53:23Z |
publishDate | 2016-11-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Pediatric Health, Medicine and Therapeutics |
spelling | doaj.art-34b592473f41406cba0d194d2f032c622022-12-21T19:08:08ZengDove Medical PressPediatric Health, Medicine and Therapeutics1179-99272016-11-01Volume 714915330064Resource and cost considerations in treating hypoplastic left heart syndromeUrencio MGreenleaf CSalazar JDDodge-Khatami AMiguel Urencio,1 Chris Greenleaf,1 Jorge D Salazar,2 Ali Dodge-Khatami2 1Division of Cardiothoracic Surgery, 2Children’s Heart Center, University of Mississippi Medical Center, Jackson, MS, USA Abstract: Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, when surgical treatment was first undertaken with the Norwood I operation as the first of 3-staged operations. Since then, operative survival rate of stage I has risen from 53% to over 90% in the current era, not only thanks to technical advances in surgery but also through prenatal diagnosis and imaging, enhanced cardiopulmonary bypass technology, better perioperative intensive care, and closer interstage monitoring. The improvements in patient outcomes achieved through rigorous multidisciplinary teamwork have come at a tremendous cost in manpower and resources, making HLHS still a challenge to all congenital heart programs, established or emerging. We review the various surgical steps to treat HLHS and their current expected outcomes, and put into perspective cost considerations compared to other more “simple” congenital heart defects. Keywords: hypoplastic left heart syndrome, Norwood, congenital heart diseasehttps://www.dovepress.com/resource-and-cost-considerations-in-treating-hypoplastic-left-heart-sy-peer-reviewed-article-PHMTHypoplastic Left Heart SyndromeNorwoodCongenital Heart Disease |
spellingShingle | Urencio M Greenleaf C Salazar JD Dodge-Khatami A Resource and cost considerations in treating hypoplastic left heart syndrome Pediatric Health, Medicine and Therapeutics Hypoplastic Left Heart Syndrome Norwood Congenital Heart Disease |
title | Resource and cost considerations in treating hypoplastic left heart syndrome |
title_full | Resource and cost considerations in treating hypoplastic left heart syndrome |
title_fullStr | Resource and cost considerations in treating hypoplastic left heart syndrome |
title_full_unstemmed | Resource and cost considerations in treating hypoplastic left heart syndrome |
title_short | Resource and cost considerations in treating hypoplastic left heart syndrome |
title_sort | resource and cost considerations in treating hypoplastic left heart syndrome |
topic | Hypoplastic Left Heart Syndrome Norwood Congenital Heart Disease |
url | https://www.dovepress.com/resource-and-cost-considerations-in-treating-hypoplastic-left-heart-sy-peer-reviewed-article-PHMT |
work_keys_str_mv | AT urenciom resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome AT greenleafc resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome AT salazarjd resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome AT dodgekhatamia resourceandcostconsiderationsintreatinghypoplasticleftheartsyndrome |